Filter Results :

Your search for antibod returned 133 reports

Sort by


Global Breast Cancer Monoclonal Antibodies Market Outlook 2020

22 May 2015  |  Published by:  KuicK Research
Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and eff...

$ 1,800.00
$ 1,530.00
( Save 15% )

Read More

Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019

01 May 2015  |  Published by:  MarketsandMarkets
Report Description Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have l...

$ 4,650.00

Read More

The 2016-2021 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for therapeutic Monoclonal Antibody (Mab)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollar...

$ 995.00

Read More

Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-Dickkopf-1 (Dkk-1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-Dickkopf-1 (Dkk-1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in...

$ 1,250.00

Read More

Anti-CD40 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD40 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD40 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

$ 1,250.00

Read More

Anti-CD25 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD25 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD25 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

$ 1,250.00

Read More

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD279 (PD-1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD279 (PD-1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing a...

$ 1,250.00

Read More

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

01 Apr 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of A...

$ 1,415.15

Read More

Anti-CD4 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD4 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD4 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing d...

$ 1,250.00

Read More

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD274 (PD-L1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD274 (PD-L1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing...

$ 1,250.00

Read More

Anti-CD22 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD22 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD22 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

$ 1,250.00

Read More

The 2016-2021 World Outlook for Monoclonal Antibody (MAb)-Based Products

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for Monoclonal Antibody (MAb)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perc...

$ 995.00

Read More

Anti-CS1 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CS1 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CS1 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing d...

$ 1,250.00

Read More

Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-Mucin 1 (MUC1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-Mucin 1 (MUC1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensi...

$ 1,250.00

Read More

Anti-CD38 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD38 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD38 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

$ 1,250.00

Read More
Total 133 records.